Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Ultrasound Guided IV Access in a Pediatric Emergency Department (USgIV)

10 maj 2018 uppdaterad av: Children's Hospital of Philadelphia

A Randomized Control Trial of Ultrasound Guided IV Access in the Pediatric Emergency Department

The primary objective is to determine whether the use of ultrasound guidance compared to standard IV access improves the proportion of successful IV placement on a first attempt for children in a pediatric emergency department who have predicted difficult access by a validated score. Secondary objectives include determining whether ultrasound-guided IV access lowers the overall number of IV attempts and/or reduces time to IV access. The investigators will also examine the duration of IV access and any complications related to IV access in both the traditional and ultrasound guided IV access group.

Studieöversikt

Detaljerad beskrivning

The proposed study is a randomized trial of ultrasound guided IV access compared to traditional IV access in patients determined to have difficult IV access based on the Difficult Intravenous Access (DIVA) scale. Patients enrolled in the study will be randomized to traditional IV access or ultrasound guided IV access. If randomized to ultrasound guided IV access, the IV will be placed under direct visualization. Following IV placement or when attempts at IV access have ceased, the patient and family will be asked to complete a series of questions related to their satisfaction regarding IV placement. The follow-up phase examining duration of the IV and any related complications will continue until the IV placed as part of the study has been removed.

Studietyp

Interventionell

Inskrivning (Faktisk)

163

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Pennsylvania
      • Philadelphia, Pennsylvania, Förenta staterna, 19104
        • The Children's Hospital of Philadelphia

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

Inte äldre än 18 år (Barn, Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Emergency department patients ages 0-18 years
  • Requiring IV access as determined by emergency department attending physician
  • Predicted difficult IV access as defined by a revised DIVA score >3

Exclusion Criteria:

  • Unstable patients triaged as a Level 1 triage acuity
  • Patients who refuse IV access
  • Non-English speaking parent/guardian
  • No study team member available to enroll patient
  • Parent/guardian does not consent
  • Allergy to ultrasound gel

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Ultrasound guided intravenous access
This group will have their IV placed by ultrasound guidance.
The ultrasound machine will be used to guide intravenous line placement in patients randomized to the ultrasound guided intravenous line group
Placebo-jämförare: Traditional intravenous access
The patients randomized to traditional IV access will have their IVs placed by standard technique.
Placement by experienced nurse using standard IV techniques
Andra namn:
  • Standard of Care arm

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Success of Initial IV Placement Attempt
Tidsram: Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
Patients will be randomized to traditional IV placement or ultrasound guided IV placement immediately after enrollment. The IV will be placed directly following enrollment.
Participants will be followed through the duration of emergency department stay, an expected average of 4 hours

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Measure the overall number of IV attempts..
Tidsram: Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
We will record the number of IV attempts made until a patient has a successfully placed IV or further attempts are aborted.
Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
Time to IV access.
Tidsram: Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
The time from enrollment until successful IV access is obtained will be measured.
Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
Patient & family satisfaction with IV placement method.
Tidsram: Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
A survey will be given to parents and patients over age 12 years to ask them about their experience with the IV placement.
Participants will be followed through the duration of emergency department stay, an expected average of 4 hours
Compare the survival (in length of time) of IV access
Tidsram: Participants will be followed through the duration of hospital stay, expected average of 5 days
We will track the IVs placed as part of the study through the electronic medical record to determine when and why they were removed and if there were any associated complications.
Participants will be followed through the duration of hospital stay, expected average of 5 days

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Joseph J Zorc, MD, MSCE, Children's Hospital of Philadelphia

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 maj 2014

Primärt slutförande (Faktisk)

2 december 2016

Avslutad studie (Faktisk)

1 mars 2017

Studieregistreringsdatum

Först inskickad

24 april 2014

Först inskickad som uppfyllde QC-kriterierna

28 april 2014

Första postat (Uppskatta)

29 april 2014

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

15 maj 2018

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 maj 2018

Senast verifierad

1 maj 2018

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 13-010758

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera